United States· US:80725-630_120a3a37-e84a-406b-94f8-243897706dc6
TABLOID
A medicinal product containing thioguanine, registered in United States by Waylis Therapeutics LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- THIOGUANINE
- Manufacturer
- Waylis Therapeutics LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1180725630251 BOTTLE in 1 CARTON (80725-630-25) / 25 TABLET in 1 BOTTLE
- ndc1180725-630-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Thioguanine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLanvis 40mg tabletsAspen Pharma Trading Ltd
- SwedenLanvis 40 mg TablettAspen Pharma Trading Limited
- SpainLANVIS 40 MG COMPRIMIDOSAspen Pharma Trading Limited
- NorwayLanvisGlaxoSmithKline
- FranceLANVIS 40 mg, comprimé sécableASPEN PHARMA TRADING (IRLANDE)
- SwitzerlandLanvis
- IrelandLanvis 40mg TabletsAspen Pharma Trading Limited
- NetherlandsLanvis 40 mg tablettenAspen Pharma Trading Limited
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Thioguanin Aspen
- Belgium · Lanvis
- Czechia · Lanvis
- Germany · Thioguanin Aspen
- Estonia · Lanvis
- Spain · Lanvis
- France · Lanvis
- Ireland · Lanvis
- Italy · Tioguanina
- Lithuania · Lanvis
- Netherlands · Lanvis, Thiosix
- Poland · Lanvis
- Romania · Lanvis
- Sweden · Lanvis
- Slovakia · Lanvis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/343d0a2e-ab94-4da3-b5dc-c0bce6c56ae2 GET /v1/drugs/343d0a2e-ab94-4da3-b5dc-c0bce6c56ae2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "40",
"substance": "THIOGUANINE",
"productndc": "80725-630",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA012429",
"marketing_category": "NDA"
}See everything about thioguanine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.